Who are Elite Pharmaceuticals, Inc.'s main suppliers?

Elite Pharmaceuticals, Inc. (ELTP) key suppliers include: BUREL-PHARMACEUTICALS-INC, PRASCO-LLC, SUPPLIER, LANNETT-COMPANY-INC, PRAXGEN-PHARMACEUTICALS-LLC. View the full supplier network at chainsifter.com/chain/ELTP.

Who are Elite Pharmaceuticals, Inc.'s major customers?

Elite Pharmaceuticals, Inc. (ELTP) key customers include: CUSTOMER, EPIC-PHARMA-LLC. View the full customer network at chainsifter.com/chain/ELTP.

What sector is Elite Pharmaceuticals, Inc. in?

Elite Pharmaceuticals, Inc. (ELTP) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

ELTP Supply Chain: Elite Pharmaceuticals, Inc. Supplier List & 10 Relationships

5Suppliers

2Customers

3Debt Items

0Related Chains

Elite Pharmaceuticals, Inc. Suppliers

Ticker	Name	Confidence	Evidence
BUREL-PHARMACEUTICALS-INC	BUREL-PHARMACEUTICALS-INC	90%	the Company entered into a license, manufacturing and supply agreement with Prasco, LLC and its affiliate Burel Pharmaceuticals, Inc.
PRASCO-LLC	PRASCO-LLC	90%	the Company entered into a license, manufacturing and supply agreement with Prasco, LLC and its affiliate Burel
SUPPLIER	SUPPLIER	90%	Three suppliers accounted for approximately 71 % of the Company's purchases of raw materials for the nine months ended December 31, 2024.
LANNETT-COMPANY-INC	LANNETT-COMPANY-INC	85%	The Company has entered into two separate license, supply and distribution agreements with Lannett Company Inc.
PRAXGEN-PHARMACEUTICALS-LLC	PRAXGEN-PHARMACEUTICALS-LLC	80%	The product is jointly owned by Elite and Praxgen Pharmaceuticals LLC

Elite Pharmaceuticals, Inc. Customers

Ticker	Name	Confidence	Evidence
CUSTOMER	CUSTOMER	90%	Two customers accounted for approximately 76 % of the Company's accounts receivable as of December 31, 2024.
EPIC-PHARMA-LLC	EPIC-PHARMA-LLC	90%	we entered into a license, manufacturing and supply agreement with Epic Pharma LLC to market the two Elite generic products described below in the United States

Elite Pharmaceuticals, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ELTP-DEBT-9270	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2017-03-31.
ELTP-DEBT-9269	Warrants outstanding: 0.1521	90%	xbrl warrant detail from xbrl 2023-12-31.
ELTP-DEBT	Debt stack $6.1M	90%	Market cache reports total debt of $6.1M.

Elite Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Elite Pharmaceuticals, Inc..

Elite Pharmaceuticals, Inc. Ownership

Holder	Name	Confidence	Evidence
ELTP-OWNER-KELLEHER-FINANCIAL-ADVISORS	KELLEHER FINANCIAL ADVISORS	90%	13F overlay lists KELLEHER FINANCIAL ADVISORS as top holder; 1 tracked holders.

Elite Pharmaceuticals, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Elite Pharmaceuticals, Inc. Supply Chain